DaVita Inc. today announced that its Board of Directors appointed a new independent director, Wendy Schoppert, to join the Board, effective as of July 14, 2023. “We’re pleased to welcome Wendy to DaVita’s board,” said Pam Arway, independent chair of the DaVita Inc. Board of…
NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal first quarter ending June 30, 2023. Fiscal 2024 First Quarter Highlights “We are pleased to report solid top…
NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced Kymera Independent Physicians multi-specialty group selected NextGen® Enterprise EHR – a powerful, all-encompassing electronic health record to expand access to care, while increasing clinical productivity, enriching patient experience, and…
Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it has received a top score of 100% in the 2023 Disability Equality Index® (DEI), a comprehensive benchmarking tool that measures disability inclusion in the workplace.…
The newest addition to the Siemens Healthineers Atellica in vitro diagnostics portfolio, the Atellica CI Analyzer for immunoassay and clinical chemistry testing, has received FDA clearance and is now available in many of the world’s major markets. Labs operating at low to…
Elevance Health, Inc. (NYSE: ELV) reported second quarter 2023 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share. “Our solid execution and continued progress of our strategy to become a lifetime trusted…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of KEYTRUDA, Merck’s anti-PD-1 therapy, in…
The global adhesion barrier market is anticipated to reach USD 1.50 billion by 2030, registering a CAGR of 7.3% over the forecast period. The primary factors contributing to the growth of the market are the rising incidence of surgical adhesions,…
Transdermal CNS drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically…
The global foot and ankle devices market size is expected to reach USD 7.1 billion by 2030, registering a CAGR of 6.9% This growth is due to the rapidly developing healthcare infrastructure, the increasing number of foot & ankle surgical…
Aya Healthcare, the largest healthcare talent software and staffing company in the U.S., was named to FORTUNE’s list of Best Workplaces for Millennials for 2023. FORTUNE partnered with Great Place to Work® to highlight companies that are fulfilling Generation Y’s…
Geisinger Health Plan (GHP) has selected Navitus Health Solutions, LLC to deliver best-in-class pharmacy benefit management (PBM) services across all lines of business. The change will go into effect Jan. 1, 2024. GHP serves more than 600,000 members throughout Pennsylvania.…